Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Further information selected
Process STA Standard
ID number 6480

Provisional Schedule

Committee meeting: 1 02 July 2025
Expected publication 11 September 2025

Project Team

Project lead Vonda Murray

Email enquiries

Stakeholders

Companies sponsors Sanofi (dupilumab)
Others Department of Health and Social Care
  Health Technology Wales (HTW)
  NHS England
Patient carer groups Allergy UK
  Asthma + Lung UK
  Fifth Sense
  Muslim Council of Britain
  NARA - The Breathing Charity
  Sinus UK
  South Asian Health Foundation
  Specialised Healthcare Alliance
Professional groups Association of Anaesthetists of Great Britain and Ireland (AAGBI)
  Association for Respiratory Technology and Physiology
  Association of Respiratory Nurse Specialists
  British Association of Otorhinolaryngologists, Head and Neck Surgeons (ENT UK)
  Association of Surgeons of Great Britain and Ireland (ASGBI)
  British Geriatrics Society
  British Thoracic Society
  ENT UK
  ILD-IN: Interstitial Lung Diseases Interdisciplinary Network
  National Heart and Lung Institute
  Primary Care Respiratory Society UK
  Royal College of Anaesthetists
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal College of Surgeons
  Royal Pharmaceutical Society
  Royal Society of Medicine
  UK Clinical Pharmacy Association
Comparator companies None
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health - Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Government
  Welsh Health Specialised Services Committee
Relevant research groups British Association for Lung Research
  Cochrane Airways Group
  Genomics England
  MRC Clinical Trials Unit
  National Institute for Health Research

Timeline

Key events during the development of the guidance:

Date Update
19 November 2024 Invitation to participate
19 November 2024 In progress
22 October 2024 - 05 November 2024 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

For further information on how we select topics for development, please see our page about topic selection